A Viroptic, Trifluorothymidine, Trifluridine CEP of the European Pharmacopoeia monograph is often referred to as a Viroptic, Trifluorothymidine, Trifluridine Certificate of Suitability (COS). The purpose of a Viroptic, Trifluorothymidine, Trifluridine CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Viroptic, Trifluorothymidine, Trifluridine EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Viroptic, Trifluorothymidine, Trifluridine to their clients by showing that a Viroptic, Trifluorothymidine, Trifluridine CEP has been issued for it. The manufacturer submits a Viroptic, Trifluorothymidine, Trifluridine CEP (COS) as part of the market authorization procedure, and it takes on the role of a Viroptic, Trifluorothymidine, Trifluridine CEP holder for the record. Additionally, the data presented in the Viroptic, Trifluorothymidine, Trifluridine CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Viroptic, Trifluorothymidine, Trifluridine DMF.
A Viroptic, Trifluorothymidine, Trifluridine CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Viroptic, Trifluorothymidine, Trifluridine CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Viroptic, Trifluorothymidine, Trifluridine suppliers with CEP (COS) on PharmaCompass.